CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.47
-0.14 (-1.63%)
At close: Sep 3, 2026, 4:00 PM EDT
8.59
+0.12 (1.42%)
After-hours: Sep 3, 2026, 6:10 PM EDT
CorMedix Employees
CorMedix had 191 employees as of December 31, 2025. The number of employees increased by 126 or 193.85% compared to the previous year.
Employees
191
Change (1Y)
126
Growth (1Y)
193.85%
Revenue / Employee
$2,420,152
Profits / Employee
$973,901
Market Cap
660.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 191 | 126 | 193.85% | 191 | 0 |
| Dec 31, 2024 | 65 | -18 | -21.69% | 64 | 1 |
| Dec 31, 2023 | 83 | 42 | 102.44% | 82 | 1 |
| Dec 31, 2022 | 41 | 11 | 36.67% | 40 | 1 |
| Dec 31, 2021 | 30 | -5 | -14.29% | 29 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Prime Medicine | 146 |
| Verastem | 102 |
| OmniAb | 89 |
| Assembly Biosciences | 73 |
| AgomAb Therapeutics NV | 62 |
CRMD News
- 2 days ago - CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference - GlobeNewsWire
- 17 days ago - CorMedix reports Q2 EPS 29c vs. 28c last year - TheFly
- 21 days ago - CorMedix Earnings Call Transcript: Q2 2026 - Transcripts
- 21 days ago - CorMedix Earnings release: Q2 2026 - Filings
- 21 days ago - CorMedix Quarterly report: Q2 2026 - Filings
- 21 days ago - Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026 - GlobeNewsWire
- 1 month ago - CorMedix price target lowered to $13 from $14 at RBC Capital - TheFly